Comments on Kamimura et al.: significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients (Q51166639)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 January 2017

Language	Label	Description	Also known as
English	Comments on Kamimura et al.: significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients	scientific article published on 27 January 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/28127626

Comments on Kamimura et al.: significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/28127626

author name string

S J Fu

1

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/28127626

Z F Sheng

2

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/28127626

language of work or name

0 references

publication date

27 January 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/28127626

Osteoporosis International

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/28127626

28

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/28127626

5

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/28127626

1755-1756

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/28127626

Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients

1 reference

https://api.crossref.org/works/10.1007%2FS00198-016-3867-1

21 January 2018

Clinician's Guide to Prevention and Treatment of Osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00198-016-3867-1

21 January 2018

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS00198-016-3867-1

21 January 2018

The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT).

1 reference

https://api.crossref.org/works/10.1007%2FS00198-016-3867-1

21 January 2018

Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial

1 reference

https://api.crossref.org/works/10.1007%2FS00198-016-3867-1

21 January 2018

Denosumab in patients with cancer and skeletal metastases: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-016-3867-1

21 January 2018

Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research

1 reference

https://api.crossref.org/works/10.1007%2FS00198-016-3867-1

21 January 2018

Identifiers

10.1007/S00198-016-3867-1

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/28127626

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/28127626

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51166639&oldid=2269700613"